Trulieve Cannabis Corp. ("Trulieve" or the "Company") (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States, will release its fourth quarter 2019 financial results on Wednesday, April 8, 2020, before markets open. Following the earnings release, management will host a conference call at 8:30 AM Eastern Time to review the financial results.

February 27, 2020 -- The European CBD market has big potential says a new survey from New Frontier Data. In fact, they found that Europe has a growing consumer base that has very positive views on CBD. Per feedback from 3,100 respondents, 74% of consumers noted that CBD has "positively impacted their lives." In addition, 41% said that their spending had increased over the last six months, with 44% expecting their spending to rise further. Better still, the Brightfield Group estimates that the European market will boom 400% over the next four years from $318 million in 2018. "CBD is just starting to take hold in Europe, with both product availability and consumer awareness still quite limited. This is a great opportunity for developed brands to enter and expand through Europe with far less competition than we're seeing in the U.S," says Brightfield Managing Director, Bethany Gomez. It's all creating sizable opportunity for companies such as Mota Ventures Inc. (CSE:MOTA) (OTCPK:PEMTF), GW Pharmaceuticals (NASDAQ:GWPH), Tilray Inc. (NASDAQ:TLRY), Green Growth Brands Inc. (CSE:GGB)(OTCQB:GGBXF), and Trulieve Cannabis Corp. (CSE:TRUL)(OTCQX:TCNNF).

The new dispensary broadens access to Florida's widest-ranging medical cannabis inventory for patients in the Stuart market